Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06194669

Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to analyze somatic mutations in the genome of normal kidney cells from patients affected by kidney cancer predisposition syndrome Von Hippel Lindau (VHL) and compare the mutation rates observed in these patients and in individuals not affected by the disease. The main questions the study aims to answer are: * Do kidney cells from VHL patients mutate more than cells from control individuals during adult life? * What mechanisms favor somatic mutation occurrence in the genome of normal kidney tubule cells? Participants will donate one blood sample and multiple urine samples. Urines will be used for kidney cell isolation, followed by cell culturing and genetic analyses. Urine samples will be collected once a year for 3-5 years. Sample collection will occur during the yearly screening program that each patient undergoes at the hospital. In case patients undergo surgical treatment of kidney tumors, samples discarded from surgery (tumor and normal kidney adjacent to tumor) will be collected and subjected to genetic analyses. Researchers will compare the number and types of mutations found in tumors and normal kidney cells from VHL-disease patients with those found in normal kidney cells from control individuals, to see if somatic mutation rates are increased in VHL-disease patients during aging.

Conditions

Interventions

TypeNameDescription
OTHERBlood and urine sample collectionOne whole blood sample per individual (3 ml) will be collected. Up to 5 urine samples per individual will be collected

Timeline

Start date
2023-06-30
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2024-01-08
Last updated
2024-01-10

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06194669. Inclusion in this directory is not an endorsement.